Litigation Details for Allergan, Inc. v. Aurobindo Pharma Limited (D. Del. 2021)
✉ Email this page to a colleague
Allergan, Inc. v. Aurobindo Pharma Limited (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-12-22 |
Court | District Court, D. Delaware | Date Terminated | 2022-07-26 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Parties | ALLERGAN, INC. | ||
Patents | 8,858,961 | ||
Attorneys | Katherine A. Helm | ||
Firms | Smith, Katzenstein, & Jenkins LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Allergan, Inc. v. Aurobindo Pharma Limited
Details for Allergan, Inc. v. Aurobindo Pharma Limited (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-12-22 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,858,961 B2. (apk) (Entered:…2021 26 July 2022 1:21-cv-01808 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |